Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma
Pre-publication versions of this article are available by contacting email@example.com.
|15 Feb 2005||Submitted||Original manuscript|
|30 Mar 2005||Reviewed||Reviewer Report - Vittorio Gebbia|
|22 Apr 2005||Reviewed||Reviewer Report - Nicolas Tsavaris|
|29 Apr 2005||Author responded||Author comments - Stefan von Delius|
|Resubmission - Version 2|
|29 Apr 2005||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|20 May 2005||Reviewed||Reviewer Report - Vittorio Gebbia|
|23 May 2005||Reviewed||Reviewer Report - Nicolas Tsavaris|
|10 Jun 2005||Author responded||Author comments - Stefan von Delius|
|Resubmission - Version 4|
|10 Jun 2005||Submitted||Manuscript version 4|
|12 Jun 2005||Editorially accepted|
|12 Jun 2005||Article published||10.1186/1471-2407-5-61|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.